Manhattan Scientifics Inc (MHTX)

[Sparroww]

Well folks, when you have Proulx recently saying that " that patient recruitment still remains challenging" and no recent updates, coupled that with a very poorly designed, cumbersome trial and no real data shared on the trials, you see the results.

You can't expect a rising stock value when you tell your shareholders that basically, the trial so far has not given them any real conclusions.

Proulx needs to update shareholders on the patient study, the MRI study, Siemens collaboration, anything positive that shareholders can hang their hats on.